Work

Supplementary Table 1 and 2 from Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table 1 and 2. Table S1 contains all of the genes tested. Table S2 describes patient selection.

DOI: 10.1158/1078-0432.22450721.v1

Authors: Yvonne Saenger, Jay Magidson, Bobby Liaw, Ellen de Moll, Sara Harcharik, Yichun Fu, Karl Wassmann, David Fisher, John Kirkwood, William K. Oh, Philip Friedlander

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361968260

Cites:

Cited by:

Related to: 10